Concepedia

Yasuko Satoh

YS

9

Publications

345

Citations

9

H-Index

1971

Active since

Affiliations

Chugai Pharma (United States)(Current)

Yasuko Satoh is an author at Chugai Pharma (United States) specializing in medicine, tumor biology, and pharmacology.

Top concepts

Publications per year

1971–2015

9

Publications

9

Alectinib Shows Potent Antitumor Activity against <i>RET</i> -Rearranged Non–Small Cell Lung Cancer

Tatsushi Kodama, Toshiyuki Tsukaguchi, Yasuko Satoh et al. · Molecular Cancer Therapeutics · 2014 · 155 citations · Full text

Mechanism of Oncogenic Signal Activation by the Novel Fusion Kinase FGFR3–BAIAP2L1

Yoshito Nakanishi, Nukinori Akiyama, Toshiyuki Tsukaguchi et al. · Molecular Cancer Therapeutics · 2015 · 60 citations · Full text

, , +17

A Novel Mechanism of EML4-ALK Rearrangement Mediated by Chromothripsis in a Patient-Derived Cell Line

Tatsushi Kodama, Noriko Motoi, Hironori Ninomiya et al. · Journal of Thoracic Oncology · 2014 · 27 citations · Full text

, , +8

Combining Onartuzumab with Erlotinib Inhibits Growth of Non–Small Cell Lung Cancer with Activating <i>EGFR</i> Mutations and HGF Overexpression

Yuji Sano, Eri Hashimoto, Noriaki Nakatani et al. · Molecular Cancer Therapeutics · 2014 · 25 citations · Full text

, , +17

Inhibition of lymphatic metastasis in neuroblastoma by a novel neutralizing antibody to vascular endothelial growth factor‐<scp>D</scp>

Kenji Kashima, Miho Watanabe, Yasuko Satoh et al. · Cancer Science · 2012 · 22 citations · Full text

, , +17

Rows per page

1–5 of 9